Vimarsana
Biggest News Aggregation in the World

Page 27 - Linical Evolution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Linical Evolution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Linical Evolution Today - Breaking & Trending Today

Taros and Welab combine to provide discovery and development services - Vimarsana News

Taros and Welab combine to provide discovery and development services

The German and Spanish companies use their relevant expertise in conjunction to provide clients with services spanning from hit generation to pre-clinical development.

Boehringer Ingelheim, Cognizant and Veeva connect using 'technology ecosystem' - Vimarsana News

Boehringer Ingelheim, Cognizant and Veeva connect using 'technology ecosystem'

Unifying medicinal development processes and data within a connected technology ecosystem will enhance collaboration, two partnering companies using a development cloud have said.

Organizations unite in bid to help patients navigate muscular dystrophy - Vimarsana News

Organizations unite in bid to help patients navigate muscular dystrophy

A partnership was announced this week (April 11) between non-profit CureDuchenne and health technology company, PicnicHealth that will provide as much data as possible to researchers while helping patients navigate complex medical systems.

University becomes Freenome's study partner in cancer screening - Vimarsana News

University becomes Freenome's study partner in cancer screening

The Institute for Population and Precision Health (IPPH) at the University of Chicago has joined private biotech company, Freenome, to become its partner as part of a study.

Pharming ship immunodeficiency drugs to the US for first time - Vimarsana News

Pharming ship immunodeficiency drugs to the US for first time

Dutch biopharmaceutical company, Pharming Group PV, has sent its first commercial shipments of a drug to treat a rare, primary immunodeficiency, to the US.